• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过生长抑素受体闪烁扫描术诊断的原发性肝神经内分泌肿瘤:一例报告

Primary hepatic neuroendocrine neoplasm diagnosed by somatostatin receptor scintigraphy: A case report.

作者信息

Akabane Miho, Kobayashi Yuta, Kinowaki Keiichi, Okubo Satoshi, Shindoh Junichi, Hashimoto Masaji

机构信息

Division of Hepatobiliary-pancreatic Surgery, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo 105-8470, Japan.

Department of Diagnostic Pathology, Toranomon Hospital, Tokyo 105-8470, Japan.

出版信息

World J Clin Cases. 2022 Mar 6;10(7):2222-2228. doi: 10.12998/wjcc.v10.i7.2222.

DOI:10.12998/wjcc.v10.i7.2222
PMID:35321183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8895177/
Abstract

BACKGROUND

Primary hepatic neuroendocrine neoplasm (NEN) is a rare condition, and it is difficult to differentiate between primary and metastatic hepatic NENs. Herein, we report a case of primary hepatic NEN that initially mimicked a hemangioma but showed a gradual increase in size on long-term careful observation.

CASE SUMMARY

A 47-year-old woman was incidentally diagnosed with a 12-mm liver mass, suspected to be a hemangioma. Since then, regular follow-up had been carried out. Ten years later, she was referred to our institute due to the tumor (located in segment 4) having increased to 20 mm. Several imaging studies depicted no apparent extrahepatic lesion. Positron emission tomography (PET)/computed tomography exhibited significant accumulation in the mass lesion, which made us consider the possibility of malignancy. Left hepatectomy was performed. The histopathological diagnosis was neuroendocrine tumor grade 2, with somatostatin receptor 2a/5 positivity. Postoperative somatostatin receptor scintigraphy (SRS) showed no other site, leading to the diagnosis of NEN of primary hepatic origin. The gradual growth of the hepatic NEN over 10 years suggested that it was likely to be a primary liver tumor.

CONCLUSION

In this case, positivity on PET and postoperative SRS may have helped determine whether the tumor was primary or metastatic.

摘要

背景

原发性肝神经内分泌肿瘤(NEN)是一种罕见疾病,难以区分原发性和转移性肝NEN。在此,我们报告一例原发性肝NEN病例,该病例最初疑似血管瘤,但经长期仔细观察后肿瘤大小逐渐增加。

病例摘要

一名47岁女性偶然被诊断出肝脏有一个12毫米的肿块,怀疑是血管瘤。此后,进行了定期随访。十年后,由于肿瘤(位于第4段)增大至20毫米,她被转诊至我院。多项影像学检查未发现明显的肝外病变。正电子发射断层扫描(PET)/计算机断层扫描显示肿块病变有明显放射性浓聚,这使我们考虑恶性肿瘤的可能性。遂行左肝切除术。组织病理学诊断为2级神经内分泌肿瘤,生长抑素受体2a/5阳性。术后生长抑素受体闪烁扫描(SRS)未发现其他部位有病变,从而诊断为原发性肝源性NEN。肝NEN在10年内逐渐生长,提示其可能为原发性肝肿瘤。

结论

在本病例中,PET阳性及术后SRS可能有助于确定肿瘤是原发性还是转移性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b6a/8895177/23a5f5ada6af/WJCC-10-2222-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b6a/8895177/3d41923abc77/WJCC-10-2222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b6a/8895177/cd445ef315fe/WJCC-10-2222-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b6a/8895177/23a5f5ada6af/WJCC-10-2222-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b6a/8895177/3d41923abc77/WJCC-10-2222-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b6a/8895177/cd445ef315fe/WJCC-10-2222-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b6a/8895177/23a5f5ada6af/WJCC-10-2222-g003.jpg

相似文献

1
Primary hepatic neuroendocrine neoplasm diagnosed by somatostatin receptor scintigraphy: A case report.通过生长抑素受体闪烁扫描术诊断的原发性肝神经内分泌肿瘤:一例报告
World J Clin Cases. 2022 Mar 6;10(7):2222-2228. doi: 10.12998/wjcc.v10.i7.2222.
2
Clinical usefulness of Somatostatin Receptor Scintigraphy in the Diagnosis of Neuroendocrine Neoplasms.生长抑素受体闪烁扫描术在神经内分泌肿瘤诊断中的临床应用价值
Asia Ocean J Nucl Med Biol. 2022 Winter;10(1):1-13. doi: 10.22038/AOJNMB.2021.56254.1390.
3
The Value of Somatostatin Receptor Scintigraphy (SRS) in Patients with NETG1/G2 Pancreatic Neuroendocrine Neoplasms (p-NENs).生长抑素受体闪烁扫描术(SRS)在G1/G2级胰腺神经内分泌肿瘤(p-NENs)患者中的价值
Nucl Med Rev Cent East Eur. 2019;22(1):1-7. doi: 10.5603/NMR.a2018.0032. Epub 2018 Oct 2.
4
Primary hepatic neuroendocrine neoplasm presenting as a massive cystic liver tumor mimicking mucinous cystic neoplasm of the liver: A case report and literature review.表现为巨大囊性肝肿瘤并酷似肝黏液性囊性肿瘤的原发性肝神经内分泌肿瘤:1例报告及文献复习
Oncol Lett. 2023 May 31;26(1):304. doi: 10.3892/ol.2023.13890. eCollection 2023 Jul.
5
Case report: Peritumoral hepatic steatosis in a patient with a metastatic somatostatin-producing oligosymptomatic neuroendocrine neoplasm.病例报告:一名患有产生生长抑素的少症状转移性神经内分泌肿瘤患者的瘤周肝脂肪变性。
Front Oncol. 2022 Dec 2;12:1013017. doi: 10.3389/fonc.2022.1013017. eCollection 2022.
6
Limited role of carbidopa-assisted F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms.卡比多巴辅助 F-FDOPA PET/CT 在散发性无功能性胃十二指肠神经内分泌肿瘤患者中的作用有限。
Ann Nucl Med. 2019 Sep;33(9):697-707. doi: 10.1007/s12149-019-01378-1. Epub 2019 Jun 15.
7
Primary Presacral Neuroendocrine Tumor Presenting as Multiple Liver Metastasis: A Case Report.原发性骶前神经内分泌肿瘤表现为多发肝转移:病例报告。
Am J Case Rep. 2023 Jul 1;24:e939614. doi: 10.12659/AJCR.939614.
8
Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.PET/CT 68Ga生长抑素受体显像对既往诊断为99mTc-EDDA/HYNIC-TOC SPECT的患者后续治疗的影响。
Nucl Med Rev Cent East Eur. 2016;19(2):88-92. doi: 10.5603/NMR.2016.0018.
9
Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.奥曲肽受体显像在非(131)I 摄取的转移性分化型甲状腺癌中评估(177)Lu-DOTATATE 肽受体放射性核素治疗的可行性:适合肽受体放射性核素治疗的患者比例较低,且存在嗜铬粒蛋白 A 水平阳性神经内分泌分化的证据。
Clin Nucl Med. 2014 Jun;39(6):505-10. doi: 10.1097/RLU.0000000000000429.
10
NEN - the role of somatostatin receptor scintigraphy in clinical setting.神经内分泌肿瘤——生长抑素受体闪烁扫描术在临床中的作用
Nucl Med Rev Cent East Eur. 2016;19(2):118-25. doi: 10.5603/NMR.2016.0023.

引用本文的文献

1
Rapid Progression of Primary Hepatic Neuroendocrine Carcinoma: A Case Report Demonstrating Drastic Oncological Behavior.原发性肝神经内分泌癌的快速进展:一例显示出剧烈肿瘤行为的病例报告
Am J Case Rep. 2025 Aug 25;26:e948500. doi: 10.12659/AJCR.948500.
2
Primary Hepatic Neuroendocrine Carcinoma: A Rare Entity.原发性肝神经内分泌癌:一种罕见的实体瘤。
ACG Case Rep J. 2024 Jul 11;11(7):e01411. doi: 10.14309/crj.0000000000001411. eCollection 2024 Jul.
3
Extended Left Hemihapatectomy with Right Hepatic Artery Reconstruction for Primary Hepatic Neuroendocrine Neoplasm: A Brief Report.

本文引用的文献

1
Role of Combined [Ga]Ga-DOTA-SST Analogues and [F]FDG PET/CT in the Management of GEP-NENs: A Systematic Review.联合使用[镓]镓-多柔比星生长抑素类似物和[氟]氟代脱氧葡萄糖PET/CT在胃肠胰神经内分泌肿瘤管理中的作用:一项系统评价
J Clin Med. 2019 Jul 13;8(7):1032. doi: 10.3390/jcm8071032.
2
The Value of Somatostatin Receptor Scintigraphy (SRS) in Patients with NETG1/G2 Pancreatic Neuroendocrine Neoplasms (p-NENs).生长抑素受体闪烁扫描术(SRS)在G1/G2级胰腺神经内分泌肿瘤(p-NENs)患者中的价值
Nucl Med Rev Cent East Eur. 2019;22(1):1-7. doi: 10.5603/NMR.a2018.0032. Epub 2018 Oct 2.
3
Management of Liver Neuroendocrine Tumors in 2018.
左半肝切除术联合右肝动脉重建治疗原发性肝脏神经内分泌肿瘤:简要报告。
Am J Case Rep. 2024 Jun 18;25:e943721. doi: 10.12659/AJCR.943721.
2018年肝脏神经内分泌肿瘤的管理
JAMA Oncol. 2018 Nov 1;4(11):1605-1606. doi: 10.1001/jamaoncol.2018.3035.
4
Primary hepatic neuroendocrine tumor case with a preoperative course of 26 years: A case report and literature review.原发性肝神经内分泌肿瘤病例,术前病程 26 年:病例报告及文献复习。
World J Gastroenterol. 2018 Jun 28;24(24):2640-2646. doi: 10.3748/wjg.v24.i24.2640.
5
Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors.生长抑素受体闪烁扫描术在日本胃肠胰神经内分泌肿瘤患者中的临床应用价值
Digestion. 2017;96(1):13-20. doi: 10.1159/000470838. Epub 2017 Jun 14.
6
The SCARE Statement: Consensus-based surgical case report guidelines.SCARE 声明:基于共识的外科手术病例报告指南。
Int J Surg. 2016 Oct;34:180-186. doi: 10.1016/j.ijsu.2016.08.014. Epub 2016 Sep 7.
7
Primary hepatic neuroendocrine tumors: clinical characteristics and imaging features on contrast-enhanced ultrasound and computed tomography.原发性肝神经内分泌肿瘤:超声造影和 CT 的临床特征及影像学表现。
Abdom Radiol (NY). 2016 Sep;41(9):1767-75. doi: 10.1007/s00261-016-0770-3.
8
Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology.原发性肝脏神经内分泌肿瘤:CT与MRI特征与病理的比较
Cancer Imaging. 2015 Aug 15;15(1):13. doi: 10.1186/s40644-015-0046-0.
9
Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach.惰性晚期神经内分泌肿瘤(NENs)根治性肝转移术后的进展和生存结果支持积极的手术方法。
Surgery. 2011 Feb;149(2):209-20. doi: 10.1016/j.surg.2010.06.008. Epub 2010 Aug 2.
10
Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.神经内分泌肿瘤的功能成像:生长抑素受体闪烁显像、123I-MIBG 闪烁显像和 18F-FDG PET 的头对头比较。
J Nucl Med. 2010 May;51(5):704-12. doi: 10.2967/jnumed.109.069765. Epub 2010 Apr 15.